# Sujay Jadhav

> Sujay Jadhav is the San Francisco-based CEO of Verana Health, an Australian-raised electronic engineer and enterprise-software operator whose career runs from launching a paging company in Cambodia at 23 to leading goBalto through its acquisition by Oracle. Since joining Verana in 2021, he has focused the company on turning fragmented clinical records into curated real-world evidence, and in 2026 led its merger with oncology-data specialist COTA.

- **Role:** Chief Executive Officer at Verana Health
- **Organizations:** Verana Health, Oracle, goBalto, Model N, Commerce One, Booz Allen & Hamilton, Singapore Telecom
- **Education:** Bachelor's degree in electronic engineering, University of South Australia, MBA, Harvard University
- **Known for:** At age 23, led the launch of a paging subsidiary in Cambodia that introduced the first Cambodian-character pager and reported a 90% first-year market share., Helped guide Model N toward its 2013 initial public offering., Refocused goBalto on clinical-trial study startup and led the company through its 2018 acquisition by Oracle.

## Career timeline

- **1993-1996** — Worked at Singapore Telecom, beginning as a telecom engineer and later leading a paging subsidiary in Cambodia.
- **1998-2000** — Worked as an associate at Booz Allen & Hamilton.
- **1999-2013** — Held a succession of product, business-development, life-sciences and corporate-strategy roles at Model N, helping oversee its transition to a public company.
- **2003** — Served briefly as Senior Director of Product Marketing at Commerce One.
- **2013-2018** — Led goBalto as CEO, sharpening its focus on clinical-trial study startup and overseeing its acquisition by Oracle.
- **2018-2021** — Served as Global Vice President in Oracle's Health Sciences Global Business Unit, running product and engineering teams.
- **2021** — Appointed Chief Executive Officer of Verana Health.
- **2026** — Led Verana Health through its merger with oncology real-world-data company COTA.

## Achievements

- At age 23, led the launch of a paging subsidiary in Cambodia that introduced the first Cambodian-character pager and reported a 90% first-year market share.
- Helped guide Model N toward its 2013 initial public offering.
- Refocused goBalto on clinical-trial study startup and led the company through its 2018 acquisition by Oracle.
- Was appointed CEO of Verana Health in August 2021 after leading product and engineering teams in Oracle's Health Sciences unit.
- Led Verana Health's 2026 merger with COTA, combining specialty real-world-data capabilities across oncology, ophthalmology, urology and neurology.

## Latest updates

- **2026-09** — Verana Health released Agent Claire for Life Sciences, a set of disease-specific AI agents that lets research teams query real-world datasets conversationally while exposing the underlying query logic for validation.
- **2026-07** — Outlined practices for using AI-backed real-world data across clinical development, market access and commercial decision-making.
- **2026-03** — Joined COTA Chief Medical Officer C.K. Wang to discuss how the combined company can use real-world data for trial design, recruitment and regulatory decision-making.
- **2026-01** — Announced the merger of Verana Health and COTA, expanding Verana's specialty focus into oncology.
- **2025-10** — Discussed the role of machine learning and natural-language processing in extracting clinically useful signals from unstructured records, while emphasizing clinician validation.
- **2025-05** — Explained how external control arms can use real-world data to supplement conventional clinical-trial control groups in carefully selected settings.

## Links

- Website: https://veranahealth.com
- LinkedIn: https://www.linkedin.com/in/sujayjadhav

---

Profile page: https://yespress.io/sujay-jadhav
Published by YesPress — https://yespress.io
Last updated: 2026-09-26